<?xml version="1.0" encoding="UTF-8"?>
<ref id="B95-biomedicines-08-00060">
 <label>95.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bradley</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Jakes</surname>
    <given-names>A.D.</given-names>
   </name>
   <name>
    <surname>Harrington</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Pandha</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Melcher</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Errington-Mais</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <article-title>Applications of coxsackievirus A21 in oncology</article-title>
  <source>Oncolytic Virother.</source>
  <year>2014</year>
  <volume>3</volume>
  <fpage>47</fpage>
  <lpage>55</lpage>
  <pub-id pub-id-type="doi">10.2147/OV.S56322</pub-id>
  <pub-id pub-id-type="pmid">27512662</pub-id>
 </element-citation>
</ref>
